Therapie der Migräneattacke und Migräneprophylaxe
Literatur
- Diener HC, Brune K, Gerber W, Göbel H, Pfaffenrath V. Behandlung der
Migräneattacke und Migräneprophylaxe. Dtsch Ärztebl 1997;94:A3092-A3102.
- Rasmussen BK. Epidemiology of headache. Cephalalgia 1995;15:44-45.
- Headache Classification Committee of the International Headache Society.
Classification and diagnostic criteria for headache disorders, cranial
neuralgias and facial pain. Cephalalgia 1988;8(Suppl.7):1-93.
- Maytal J, Young M, Shechter A, Lipton RB. Pediatric migraine and the
International Headache Society (IHS) criteria. Neurology 1997;48:602-607.
- MacGregor EA. "Menstrual" migraine: towards a definition. Cephalalgia
1996;16:11-21.
- Honkasalo M, Kaprio J, Winter T, Heikkilä K, Sillanpää, Koskenvuo M.
Migraine and concomitant symptoms among 8167 adult twin pairs. Headache
1995;35:70-78.
- Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB. Evidence of a genetic
factor in migraine with aura: a population-based danish twin study. Ann Neurol
1999;45:242-246.
- Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SMG,
et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by
mutations in the Ca2+ channel gene CACNL1A4. Cell 1997;87:543-552.
- Gardner K, Barmada MM, Ptacek LJ, Hoffman EP. A new locus for hemiplegic
migraine maps to chromosome 1q31. Neurology 1997;49:1231-1238.
- Ducros A, Joutel A, Vahedi K, Cecillon M, Ferreira A, Bernard E, et al.
Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and
evidence of further heterogeneity. Ann Neurol 1997;52:885-890.
- Gervil M, Ulrich V, Kaprio J, Olesen J, Russell M. The relative role of
genetic and environmental factors in migraine without aura. Neurology
1999;53:995-999.
- Nyholt DR, Lea RA, Goadsby PJ, Brimage PJ, Griffiths LR. Familial typical
migraine: linkage to chromosome 19p13 and evidence for genetic heterogenity.
Neurology 1998;50:1428-1432.
- Cooke LJ, Rose MS, Becker WJ. Chninook winds and migraine headache.
Neurology 2000;54:302-307.
- Diener HC. Technische Zusatzuntersuchungen bei Kopfschmerzen: was ist
notwendig und erforderlich? Der Schmerz 1996;10:135-139.
- Pilgrim AJ. The methods used in clinical trials of sumatriptan in
migraine. Headache 1993;33:28093.
- The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study
Group. A study to compare oral sumatriptan with oral aspirin plus oral
metoclopramide in the acute treatment of migraine. Eur Neurol 1992;32:177-184.
- Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G.
The effectiveness of combined oral lysine acetylsalicylate and metoclopramide
compared with oral sumatriptan for migraine. Lancet 1995;34:923-926.
- The Multinational Oral Sumatriptan Cafergot Comparative Study Group. A
randomized, double-blind comparison of sumatriptan and Cafergot in the acute
treatment of migraine. Eur Neurol 1991;31:314-322.
- Wilkinson M, Pfaffenrath V, Schoenen J, Diener HC, Steiner T. Migraine and
cluster headache - their management with sumatriptan: a critical rewiew of the
current clinical experience. Cephalalgia 1995;15:337-357.
- Tfelt-Hansen P. Efficacy and adverse events of subcutaneous, oral, and
intranasal sumatriptan used for migraine treatment: a systematic review based
on numbers needed to treat. Cephalalgia 1998;18:532-538.
- Visser WH, Jaspers N, de Vriend RHM, Ferrari MD. Risk factors for headache
recurrence after sumatriptan: a study in 366 migraine patients. Cephalalgia
1996;16:264-269.
- Kaube H, May A, Diener HC, Pfaffenrath V. Sumatriptan misuse in daily
chronic headache. BMJ 1994;308:1573.
- Evers S, Gralow I, Bauer B, Suhr B, Buchheister A, Husstedt I-W, et al.
Sumatriptan and ergotamine overuse and drug-induced headache: a
clinicoepidemiologic study. Clin Neuropharmacol 1999;22:201-206.
- Limmroth V, Kazawara Z, Fritsche G, Diener H-C. Headache after frequent
use of serotonin agonists zolmitriptan and naratriptan. Lancet 1999;353:378.
- Dahlöf CGH, Mathew N. Cardiovascular safety of 5-HT1B/1D agonists - Is
there a cause for concern? Cephalalgia 1998;18:539-545.
- Diener H, Limmroth V. Therapie der akuten Migräneattacke: Kampf der
"Triptane". Arzneimitteltherapie 1999;17:219-226.
- Diener H, Limmroth V. Acute management of migraine: triptans and beyond.
Curr Opin Neurol 1999;12:261-267.
- Diener H, Kaube H, Limmroth V. Antimigraine drugs. J Neurol
1999;246:515-519.
- The Subcutaneous Sumatriptan International Study Group. Treatment of
migraine attacks with sumatriptan. N Engl J Med 1991;325:316-321.
- Ryan R, Elkind A, Baker CC, Mullican W, DeBussy S, Asgharnejad M.
Sumatriptan nasal spray for the acute treatment of migraine. Neurology
1997;49:1225-1230.
- Tepper SJ, Cochran A, Hobbs S, Woessner M, on the behalf of the S2B351
Study Group. Sumatriptan suppositories for the acute treatment of migraine.
Int J Clin Pract 1998;52:31-35.
- Pfaffenrath V, Cunin G, Sjonell G, Prendergast S. Efficacy and safety of
sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of
migraine: defining the optimum doses of oral sumatriptan. Headache
1998;38:184-190.
- Tfelt-Hansen P, Goadsby PJ. Naratriptan is effective and well tolerated in
the acute treatment of migraine. Neurology 1999;52:1300-.
- Salonen R. Naratriptan. Int J Clin Pract 1999;53:552-556.
- Schoenen J, Sawyer J. Zolmitriptan (Zomig, 311C90), a novel dual central
and peripheral 5HT1B/1D agonist: an overview of efficacy. Cephalalgia 1997;17
Suppl 18:28-40.
- Klein KB. A review of the efficacy of zolmitriptan (311C90): a new
treatment for migraine. In: Olesen J, Tfelt-Hansen P, editors. Frontiers in
Headache Research Headache Treatment: Trial Methodology an New Drugs. New
York: Lippincott-Raven; 1997. p. 6:263-266.
- The International 311C90 Long-Term Study Group. The long-term tolerability
and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of
migraine. An international study. Headache 1998;38:173-183.
- Ahrens SP, Farmer MV, Williams DL, Willoughby E, Jiang K, Block GA, et al.
Efficacy and safety of rizatriptan wafer for the acute treatment of migraine.
Cephalalgia 1999;19:525-530.
- Goldstein J, Ryan R, Jiang K, Getson A, Norman B, Block G, et al.
Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 and
50 mg in migraine. Headache 1998;38:737-747.
- Tfelt-Hansen P, Teall J, Rodriguez F, Giacovazzo M, Paz J, Malbecq W, et
al. Oral rizatriptan versus oral sumatriptan: a direct comparative study in
the acute treatment of migraine. Headache 1998;38:748-755.
- Visser WH, Terwindt GM, Reines SA, Jiang K, Lines CR, Ferrari MD, et al.
Rizatriptan vs sumatriptan in the acute treatment of migraine. A
placebo-controlled, dose-ranging study. Arch. Neurol. 1997;53:1132-1137.
- Diener HC. Evidence for the improved efficacy and safety of eletriptan
compared with sumatriptan. Cephalalgia 1997;17:477.
- Pryse-Philips W, on behalf of the Eletriptan Steering Committee.
Comparison of oral eletriptan (RelpaxTM) (40-80 mg) and oral sumatriptan
(50-100 mg) for the treatment of acute migraine. A randomised, placebo
controlled study in sumatriptan-naive patients. 9th Congress of the
International Headache Society, Barcelona 1999.
- Steiner TJ, on behalf of the Eletriptan Steering Committee. The efficacy,
saftey and tolerability of oral eletriptan (40 mg and 80 mg) for the acute
treatment of migraine: results of a double-blind, placebo-controlled, parallel
group clinical trial. Migraine Trust, London 1998.
- Dahlöf C. Placebo-controlled clinical trials with ergotamine in the acute
treatment of migraine. Cephalalgia 1993;13:166-171.
- Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Lainez M, Henry P, et al.
Ergotamine in the acute treatment of migraine. A review and European
consensus. Brain 2000;123:9-18.
- Reeches A, on behalf of the Eletriptan Steering Committee. Comparison of
the efficacy, safety and tolerability of oral eletriptan (RelpaxTM) and
Cafergot for the acute treatment of migraine. In: 9th Congress of the
International Headache Society; 1999; Barcelona; 1999.
- Massiou H, on Behalf of the Study Group. A comparison of sumatriptan nasal
spray 20 mg and intranasal dihydroergotamin in the acute treatment of
migraine. Poster, 3rd European Headache Conference, Sardinia 1996:56-59.
- Touchon J, Bertin L, Pilgrim AJ, Ashford E, BËs A. A comparison of
subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute
treatment of migraine. Neurology 1996;47:361-365.
- Winner P, Ricalde O, Le Force B, Saper J, Margui B. A double-blind study
of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment
of acute migraine. Arch. Neurol. 1996;53:180-184.
- Dichgans J, Diener HC, Gerber WD, Verspohl EJ, Kukiolka H, Kluck M.
Analgetika-induzierter Dauerkopfschmerz. Dtsch med Wschr 1984;109:369-373.
- Volans GN. The effect of metoclopramide on the absorption of effervescent
aspirin in migraine. Br J Clin Pharmacol 1975;2:57-63.
- Ellis GL, Delaney J, DeHart DA, Owens A. The efficacy of metoclopramide in
the treatment of migraine headache. Annals of Emergency Medicine
1993;22:191-195.
- Limmroth V, Katsarava Z, Diener H-C. Acetylsalicylic acid in the treatment
of headache. Cephalalgia 1999;19:545-551.
- Pradalier A, Chabriat H, Danchot J, Baudesson G, Joire JE. Safety and
efficacy of combined lysine acetylsalicylate and metoclopramide: repeat
intakes in migraine attacks. Headache 1999;39:125-131.
- Havanka-Kanniainen H. Treatment of acute migraine attack: ibuprofen and
placebo compared. Headache 1989;29:507-509.
- Nebe J, Heier M, Diener HC. Low-dose ibuprofen in self-medication of mild
to moderate headache: a comparison with acetylsalicylic acid and placebo.
Cephalalgia 1995;15:531-535.
- Lipton RB, Stewart WF, Ryan RE, Saper J, Silberstein S, Sheftell F.
Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating
migraine headache pain - Three double-blind, randomized, placebo-controlled
trials. Arch Neurol 1998;55:210-217.
- Tfelt-Hansen P, Henry P, Mulder LJ, Schaeldewaert RG, Schoenen J, Chazot
G. The effectiveness of combined oral lysine acetylsalicylate and
metoclopramide compared with oral sumatriptan for migraine. Lancet
1995;346:923-926.
- The Diclofenac-K/Sumatriptan Migraine Study Group. Acute treatment of
migraine attacks: efficacy and safety of a nonsteroidal antiinflammatory drug,
diclofenac-potassium, in comparison to oral sumatriptan and placebo.
Cephalalgia 1999;19:232-240.
- Treves TA, Streiffler M, Korczyn AD. Naproxen sodium versus ergotamine
tartrate in the treatment of acute migraine attacks. Headache 1992;32:280-282.
- Andersson PG, Hinge HH, Johansen O, Andersen CU, Lademann A, Gotzsche PC.
Double-blind study of naproxen vs placebo in the treatment of acute migraine
attacks. Cephalalgia 1989;9:29-32.
- Krymchantowski AV, Adriano M, Fernandes D. Tolfenamic acid decreases
migraine recurrence when used with sumatriptan. Cephalalgia 1999;19:186-187.
- Myllyla VV, Havanka H, Herrala L, Kangasniemi P, Rautakorpi I, Turkka J,
et al. Tolfenamic acid rapid release versus sumatriptan in the acute treatment
of migraine: Comparable effect in a double-blind, randomized, controlled,
parallel-group study. Headache 1998;38:201-207.
- Diener HC, for the ASASUMAMIG Study Group. The efficacy and safety of
intavenous acetylsalicyclic lysinate compared to subcutaneous sumatritpan and
parenteral placebo in the acute treatment of migraine. A double-blind,
double-dummy, randomised, multicenter, parallel group study. Cephalalgia
1999;19:581-588.
- Report of the Quality Standards Subcommittee of the Amercian Academy of
Neurology. Practice parameter: appropriate use of ergotamine tartrate and
dihydroergotamine in the treatment of migraine and status migrainosus.
Neurology 1995;45:585-587.
- Fisher MA, Glass S. Butorphanol (Stadol): A study in problems of current
drug information and control. Neurology 1997;48:1156-1160.
- Silberstein SD. Headaches and women: Treatment of the pregnant and
lactating migraineur. Headache 1993;33:533-540.
- Erush SC. The pharmacotherapy of migraine in pregnancy. Cephalalgia
1996;16:556-564.
- Silberstein SD. Migraine and pregnancy. Neurol Clin 1997;1:209-231.
- Überall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of
migraine in children. Neurology 1999;52:1507-1510.
- Holroyd KA, Penzien DB, Cordingley GE. Propranolol in the management of
recurrent migraine: a meta-analytic review. Headache 1991;31:333-340.
- Kangasniemi P, Hedman C. Metoprolol and propranolol in the prophylactic
treatment of classical and common migraine. A double-blind study. Cephalalgia
1984;4:91-96.
- Olsson JE, Behring HC, Forssman B, Hedman C, Hedman G, Johansson F, et al.
Metoprolol and propranolol in migraine prophylaxis: a double-blind multicenter
study. Acta Neurol Scand 1984;70:160-168.
- Sorensen PS, Larsen BH, Rasmussen MJK, Kinge E, Iversen H, Alslev T, et
al. Flunarizine versus metoprolol in migraine prophylaxis: a double-blind,
randomized parallel group study of efficacy and tolerability. Headache
1991;31:650-657.
- Steiner TJ, Joseph R, Hedman C, Clifford Rose F. Metoprolol in the
prophylaxis of migraine: parallel group comparison with placebo and
dose-ranging follow-up. Headache 1988;28:15-23.
- van de Ven LLM, Franke CL, Koehler PJ, on behalf of the Investigators.
Prophylactic treatment of migraine with bisoprolol: a placebo-conrolled study.
Cephalalgia 1997;17:596-599.
- Wörz R, Reinhardt-Benmalek B, Grotemeyer KH, Foh M. Bisoprolol and
metoprolol in the prophylactic treatment of migraine with and without aura - a
randomized double-blind cross-over multicenter study. Cephalalgia 1991;11
Suppl 11:152-153.
- Holroyd KA, Penzien DB, Rokicki LA, Cordingley GE. Flunarizine vs
propranolol: a meta-analysis of clinical trials. Headache 1992; 32:256
- Arnold G, Einhäupl KM. Valproinsäure in der prophylaktischen Behandlung
der Migräne. Nervenarzt 1998;69:913-918.
- Diener HC, Gendolla A, Limmroth V. Valproinsäure in der Migräneprophylaxe.
Akt Neurol 1996;23:265-268.
- Klapper J, on behalf of the Divalproex Sodium in Migraine Prophylaxis
Study Group. Divalproex sodium in migraine prophylaxis: a dose-controlled
study. Cephalalgia 1997;17:103-108.
- Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, et
al. Migraine prophylaxis with divalproex. Arch Neurol 1995;52:281-286.
- Silberstein SD. Methysergide. Cephalalgia 1998;18:421-435.
- Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral
magnesium: results from a prospective, multi-center, placebo-controlled and
double-blind randomized study. Cephalalgia 1996;16:257-263.
- Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, et
al. Magnesium in the prophylaxis of migraine - a double-blind,
placebo-controlled study. Cephalalgia 1996;16:436-440.
- Steiner TJ, Findley LJ, Yuen AWC. Lamotrigine versus placebo in the
prophylaxis of migraine with and without aura. Cephalalgia 1997;17:109-112.
- Bussone G, Cerbo R, Martucci N, Micieli G, Zanferrari C, Grazzi L, et al.
Alpha-dihydroergocryptine in the prophylaxis of migraine: a multicenter
double-blind study versus flunarizine. Headache 1999;39:426-431.
- Andrasik F. Behavioral mangement of migraine. Biomedicine and
Pharmacotherapy 1996;50:52-57.
- Hermann C, Kim M, Blanchard EB. Behavioural and prophylactic intervention
studies of pediatric migraine: an exploratoy meta-analysis. Pain
1995;60:239-256.
- Holroyd KA, Penzien DB. Pharmacological versus non-pharmacological
prophylaxis of recurrent migraine headache: a meta-analytic review of clinical
trials. Pain 1990;42:1-13.
- Holroyd KA, Penzien DB. Psychosocial interventions in the management of
recurrent headache disorders: overview and effectiveness. Behavioral Medicine
1994;20:53-63.
- Reid GJ, McGrath PJ. Psychological treatments for migraine. Biomedicine
and Pharmacotherapy 1996;50:58-63.
- Jacobson E. Progressive relaxation. Chicago: University of Chicago Press;
1938.
- Gauthier JG, Carrier S. Long-term effects of biofeedback on migraine
headache: A prospective follow-up study. Headache 1991;31:605-612.
- Gerber WD, Miltner W, Gabler H, Hildenbrandt E, Larbig W. Bewegungs- und
Sporttherapie bei chronischen Kopfschmerzen. In: Gerber WD, Miltner W, Mayer
K, editors. Verhaltensmedizin: Ergebnisse und Perspektiven interdisziplinärer
Forschung. Weinheim: edition medizin; 1987. p. 55-66.
- Darling M. Exercise and migraine: a critical review. J Sports Med Phys Fit
1991;31:294-302.
- Taubert K. Transkutane elektrische Nervenstimulation (TENS) bei Kopf- und
Gesichtsschmerzen. Z Ÿrtzl Fortbild 1991;85:31-36.
- Taubert K. Grundlagen für den Einsatz von Physiotherapie bei primären
Kopfschmerzen. Z Ÿrztl Fortb 1991;85:19-22.
- Walach H, Haeusler W, Lowes T, Mussbach D, Schamell U, Springer W, et al.
Classical homeopathic treatment of chronic headaches. Cephalalgia
1997;17:119-126.
- Whitmarsch TE, Coleston-Shields DM, Steiner TH. Double-blind randomized
placebo-controlled study of homoeopathic prophylaxis of migraine. Cephalalgia
1997;17:600-604.
- Ernst E. Homeopathic prophylaxis of headache and migraine. A systematic
review. J Pain Symptom Manage 1999;18:353-357.
- Melchart D, Linde K, Fischer P, White A, Allais G, Vickers A, et al.
Acupuncture for recurrent headaches: a systematic review of randomized
controlled trials. Cephalalgia 1999;19(779-786):779-786.
- Mayer H, Ditzinger G, Knoblauch P, Richter C. Feverfew-eine Alternative
bei Migräne. PZ Pharmazie 1992;19:26-32.
- Ferrari MD. The war of the triptans. In: EFNS Conference; 1999; Lisabon;
1999.
DMKG